In parallel to increased ATP release, tumor microenvironment conditions may increase CD39 and CD73 expression through various inflammatory mediators, such as TGF-β, IFNs, TNF, IL-1β, and prostaglandin E2. The gene discussed is ENTPD1; the disease is neoplasm.